Indonesia state pharma delays plan to sell vaccines


People line up to receive the AstraZeneca Covid-19 coronavirus vaccine at a makeshift mass vaccination clinic in Denpasar on Indonesia's resort island of Bali on July 5, 2021, as the Southeast Asian nation battles an unprecedented wave of new infections. - AFP

JAKARTA: Indonesia’s state-owned pharmaceutical company PT Kimia Farma is delaying a plan to sell Covid-19 vaccines after public backlash against the move.

The company will focus on preparing the programme first, said Ganti Winarno Putro, a spokesman for the company. Kimia Farma was earlier set to market Sinopharm Group Co shots, which were ordered for a private vaccination programme, as early as yesterday. The plan was met with questions on why the vaccines were being sold and why any company was allowed to profit from it.

Limited time offer:
Just RM5 per month.

Monthly Plan

RM13.90/month
RM5/month

Billed as RM5/month for the 1st 6 months then RM13.90 thereafters.

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Indonesia , vaccination , selling vaccines ,

   

Next In Business News

Eupe fourth-quarter profit rises 29%
Meta projects higher spending, weaker revenue
Buyout proposal for Anglo American could reshape copper market
A test bed for airline subscription model
Pantech seeks to list steel pipe units
AI memory boom propels SK Hynix’s numbers
Battery stocks’ rally in India likely to extend
Congo accuses Apple of using ‘blood minerals’ from war-torn east
Higher earnings for Pavilion-REIT
Airlines must now provide automatic refunds for cancelled flights

Others Also Read